-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The ascomycete
Ashbya gossypii
, a filamentous fungus, is a natural overproducer of vitamin B2 and is currently exploited for the industrial production of this vitamin. Classical mutagenesis and selection of mutants showing improved production capacities have been routinely applied with success to the development of industrial strains of A.
gossypii
that overproduce vitamin B2. However, this approach does not allow the subsequent isolation and identification of affected genes in organisms such as
A. gossypii
that lack a sexual life cycle, thus hampering further improvements of the strains on the basis of rational strategies derived from knowledge of the function of the genes involved in the process. Here, we describe an efficient in vitro
Himar1
based transposition reaction of minitransposon elements on chromosomal
A. gossypiiDNA
, which is subsequently reintroduced into
A. gossypii
by electrotransformation. Sequencing of the minitransposon insertion point in numerous transposition mutants and a limited screening of the insertional mutants demonstrate that this method can lead to the exhaustive mutagenesis of
A. gossypii
, allowing-for the first time-a genomic-scale mutational analysis of this biotechnologically important fungus.